Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.25 -0.25 (-7.14%)
As of: Oct 20, 2026 · 3:58 PM EDT

Apimeds Pharmaceuticals US (APUS) Enterprise Value (2025 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) posted Enterprise Value of $13.3 million for Q2 2026, up 39.8% from $9.51 million a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Enterprise Value (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Apimeds Pharmaceuticals US was -$6.05 million; for FY2025, it was $16.99 million.

  • Quarterly Enterprise Value has run from a low of $9.51 million in Q2 2025 to a high of $16.99 million in Q4 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Apimeds Pharmaceuticals US 5.65 Mn -13.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.30 Mn
Dec 31, 2025 16.99 Mn
Sep 30, 2025 15.40 Mn
Jun 30, 2025 9.51 Mn
API Access

Apimeds Pharmaceuticals US Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=APUS&period=max&api_key=YOUR_API_KEY